APP and Alzheimer disease: As a result, both BDP-CLQ and 5-MB-SZ demonstrated enhanced fluorescence in APP/PS1 mice compared with WT mice (Figure S32), thus confirming that BDP-CLQ retains the tendency to accumulate in AD-affected brains, as previously shown for 5-MB-SZ.